Cited by 32Adipokines, Inflammation, and Metabolic DiseasesPancreatic function and diabetesAdvanced Glycation End Products research

Immunoinflammatory mediators in the pathogenesis of diabetes mellitus

Open access
Gomes, Bárbara Festa, Accardo, Camila de Melo·2019·Einstein (São Paulo)

Abstract

Characterized as a metabolic syndrome with multiple consequences for the lives of patients, diabetes mellitus is also classified as a chronic non-communicable disease of great scope in the world. It is a complex disease, with different points of view, including the relation between inflammatory process, obesity and insulin resistance due to the performance of the various immunoinflammatory mediators - called adipokines - on glycemic homeostasis. Recent studies have precisely addressed this aspect for the development of drugs that assist in the protection of pancreatic ß cells from the damages arising from oxidative stress and inflammatory process, in order to control the hyperglycemic picture, which is characteristic of diabetes mellitus.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.31744/einstein_journal/2019rb4596

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The elevated amount of these components stimulates several signaling pathways such as inhibitor kappa beta kinase beta (IKKβ), Jun N-terminal kinase (JNK), and NF-κB signaling pathways to induce the development of insulin resistance.

    “The elevated amount of these components stimulates several signaling pathways such as inhibitor kappa beta kinase beta (IKKβ), Jun N-terminal kinase (JNK), and NF-κB signaling pathways to induce the development of insulin resistance (92, 93).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

4 of the 26 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Gomes, B. F., & Accardo, C. D. M.
Affiliations
Centro Universitário das Américas (FAM) - São Paulo (BR)
Corresponding author
Accardo, Camila de Melo
Venue
Einstein (São Paulo)
Published
2019-02-19
Volume
17
Issue
1
Pages
eRB4596-eRB4596
ISSN
  • 1679-4508 (ISSN-L)
  • 2317-6385
OpenAlex
W2915571323
Cited by
32
References
26
Citations by year
2026: 4 · 2025: 2 · 2023: 2 · 2022: 3 · 2021: 10 · 2020: 7 · 2019: 4
FWCI
4.57
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Einstein (São Paulo) (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
  • Americanae (AECID Library) (submittedVersion, cc-by-nc)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Keywords
diabetes mellitus, adipokines, insulin resistance, obesity, metabolic syndrome, glycemic homeostasis, pancreatic beta cells, oxidative stress, hyperglycemia, anti-inflammatory agents
MeSH terms
Diabetes Mellitus, Humans, Insulin Resistance, Inflammation Mediators

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review